TGF-β1 promoted MMP-2 mediated wound healing of anterior cruciate ligament fibroblasts through NF-κB

Connect Tissue Res. 2011 Jun;52(3):218-25. doi: 10.3109/03008207.2010.516849. Epub 2010 Oct 8.

Abstract

The adult human anterior cruciate ligament (ACL) has poor functional healing response. Transforming growth factor (TGF)-β1 enhances the wound repair by stimulating matrix proteins deposition as well as the proliferation and migration of cells. However, the function of the TGF-β1-induced matrix metalloproteinases' (MMPs) activities in the wound healing process is poorly understood. In this study, exogenous MMP-2 is added to mimic the TGF-β1-induced MMP-2 expression. Role of NF-κB pathway is further examined. Our results show that TGF-β1 induces dramatic elevation of MMP-2 activities and the MMP-2/tissue inhibitors of metalloproteinases ratio. Furthermore, the exogenous MMP-2 significantly promoted in vitro wound healing abilities of ACL fibroblasts that are significantly blocked with the addition of its inhibitors. TGF-β1 also increases the proliferation of ACL fibroblasts whereas MMP-2 alone does not, indicating that MMP-2 activities are not involved in the proliferation. TGF-β1-induced MMP-2 activity is inhibited by Bay11-7082 and Bay11-7085 (NF-κB inhibitors). Our results demonstrate that increased TGF-β1 facilitates the ACL healing process by promoting the fibroblasts migration and proliferation. The migration process is mediated by MMP-2 and NF-κB pathway is involved in TGF-β1-mediated MMP-2 release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anterior Cruciate Ligament / drug effects
  • Anterior Cruciate Ligament / enzymology
  • Anterior Cruciate Ligament / pathology*
  • Blotting, Western
  • Cell Proliferation / drug effects
  • Culture Media, Conditioned / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Fibroblasts / enzymology*
  • Fibroblasts / pathology*
  • Humans
  • Matrix Metalloproteinase 2 / metabolism*
  • Middle Aged
  • NF-kappa B / metabolism*
  • Nitriles / pharmacology
  • Sulfones / pharmacology
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Transforming Growth Factor beta1 / pharmacology*
  • Wound Healing / drug effects*
  • Young Adult

Substances

  • 3-(4-methylphenylsulfonyl)-2-propenenitrile
  • Culture Media, Conditioned
  • NF-kappa B
  • Nitriles
  • Sulfones
  • Tissue Inhibitor of Metalloproteinase-1
  • Transforming Growth Factor beta1
  • Tissue Inhibitor of Metalloproteinase-2
  • MMP2 protein, human
  • Matrix Metalloproteinase 2